Healthcare

Read our white paper to review key considerations for medical device companies to redefine risk, identify opportunities and adapt during Covid-19.

COVID-19 overtakes all other issues in Ipsos’ What Worries the World survey with the highest level of concern recorded for any category since the series began.

As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.

Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.

Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.

The world of pharma business insight is likely to change as it embraces a multi-data source reality.

What are the treatment options for this too-prevalent disease? And the outlook for the future as clinical outcomes evolve?

The Covid-19 epidemic has magnified the extreme fragility of the French healthcare system, facing unequaled demand for care and ending up almost bled dry. Preserving its mission implies a real transformation.

Every crisis is unique, but every crisis also has antecedents in history – especially with regard to the crisis’s effect on public opinion.